Now Open!! Grant Round 13
Could you use $200,000 - $800,000 in a Non-Dilutive Grant?
RICHMOND, VA – December 9, 2021– The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 13 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy.
“When you combine world class research with entrepreneurial management and capital, then stir, good things happen,” said Mike Grisham, CEO of Virginia Catalyst. “We are looking for passionate research scientists and entrepreneurial leaders in high-growth life science businesses in Virginia who could use $200,000 to $800,000 in non-dilutive grant funding to further a project that improves human health and advances economic development in the Commonwealth. Our Grant Round 13 is now open, and we strongly encourage interested parties to visit the Virginia Catalyst website and apply.”
Letters of Intent (LOI) must be received by March 1, 2022 at 5:00 PM EST. Projects that meet funding criteria will be invited to submit a full application by April 10, 2022.
Read the full press release here
Apply to Grant Round 13
“When you combine world class research with entrepreneurial management and capital, then stir, good things happen,” said Mike Grisham, CEO of Virginia Catalyst. “We are looking for passionate research scientists and entrepreneurial leaders in high-growth life science businesses in Virginia who could use $200,000 to $800,000 in non-dilutive grant funding to further a project that improves human health and advances economic development in the Commonwealth. Our Grant Round 13 is now open, and we strongly encourage interested parties to visit the Virginia Catalyst website and apply.”
Letters of Intent (LOI) must be received by March 1, 2022 at 5:00 PM EST. Projects that meet funding criteria will be invited to submit a full application by April 10, 2022.
Read the full press release here
Apply to Grant Round 13
Special Webinar - How to Score High and Get Funding
Previously the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
Read the full press release here
Download the presentation slides
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
Read the full press release here
Download the presentation slides
|
|
History of Awards
Our Strategic Initiatives - Actions and Results for Virginia
At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader. We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country.
|
Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization. We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs. – Michael Grisham, CEO |
Bringing Virginia Results!
Our competitive grant funding rounds brought Virginia an 11-to-1 return on investment and added over 200 jobs!
Grant Funding Program
Continuing powerful impact through our Grant Funding Program
Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
Continuing powerful impact through our Grant Funding Program
Funding through our Grant Funding Program is designed to facilitate the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. Virginia Catalyst awards these funds to help accelerate translational research and the commercialization of Virginia’s innovations. The awards, which range from $200,000 to $800,000, help fund collaborative efforts between industry and Virginia research universities.
About the Virginia Catalyst
We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and seven Virginia public research universities: Eastern Virginia Medical School, George Mason University, Old Dominion University, University of Virginia, Virginia Commonwealth University, and Virginia Tech.
Our Mission
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
